Back

An electronic health record analysis studying differences in medication use associated with renal impairment in acute heart failure

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 10 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Assistant Professor Alicia Uijl

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
The impact of age on acute heart failure outcomes beyond comorbidities
Doctor I. Amarante (Ponta Delgada, PT)
Abstract Slides Video
Presentation thumbnail
Distribution of pleural effusion as a prognostic marker among acute decompensated heart failure patients
Doctor F. Bahouth (Nazareth, IL)
Abstract Slides Video
Presentation thumbnail
Validation of a HFrEF individual lifetime risk calculator in the Portuguese population
Doctor M. Figueiredo (Barreiro, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. implications for their clinical management. COMFE registry
Doctor D. Garcia Vega (Ourense, ES)
Abstract Slides Video
Presentation thumbnail
Six-minute walk distance as a prognostic predictor in acute heart failure
Doctor K. Nakamura (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure 10

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Renal insufficiency related cardiovascular and renal outcome in patients with acute heart failure: a multi-center prospective observational cohort registry
thumbnail
Congress Presentation
Mild-to-moderate chronic kidney disease predicts underutilisation of guideline-directed medical therapies in patients with acute heart failure
thumbnail
Congress Presentation
Differences in the optimization of pharmacological treatment in patients with heart failure and reduced ejection fraction and advanced chronic kidney disease.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources